APA (7th ed.) Citation

SL, T., FS, H., JR, B., SN, G., DC, S., DF, M., . . . M, S. (2019). Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab. JAMA oncology, 5(10), 1411. https://doi.org/10.1001/jamaoncol.2019.2187

Chicago Style (17th ed.) Citation

SL, Topalian, et al. "Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab." JAMA Oncology 5, no. 10 (2019): 1411. https://doi.org/10.1001/jamaoncol.2019.2187.

MLA (9th ed.) Citation

SL, Topalian, et al. "Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated With Nivolumab." JAMA Oncology, vol. 5, no. 10, 2019, p. 1411, https://doi.org/10.1001/jamaoncol.2019.2187.